Raymond James & Associates »

Miragen Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $202k 12k 17.51
2023-12-31 $223k 10k 21.78
2023-09-30 $233k 15k 15.34
2023-06-30 $211k 8.9k 23.79
2023-03-31 $233k 9.1k 25.44